Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 1.771\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) CC(=O)N(/C=C1\SC(=S)N(c2ccccc2)C1=O)c1ccccc1
b.) Cc1cc(C)c(C(N)=O)c(NC(=O)Nc2ccccc2Cl)n1
Answer: a. CC(=O)N(/C=C1\SC(=S)N(c2ccccc2)C1=O)c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(=O)N(/C=C1\SC(=S)N(c2ccccc2)C1=O)c1ccccc1
CC(=O)N(/C=C1\SC(=S)N(c2ccccc2)C1=O)c1ccccc1
N-[(Z)-(4-oxo-3-phenyl-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]-N-phenylacetamide